sitravatinib
sitravatinib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Mirati Therapeutics, Inc. (MRTX) | Phase 2/Phase 3 |
Clinical Trials (1)
A Randomized Phase 3 Study of Sitravatinib in Combination With Nivolumab Versus Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy SAPPHIRE
Frequently asked questions
Who is developing sitravatinib?
sitravatinib is being developed by Mirati Therapeutics, Inc..
How many clinical trials involve sitravatinib?
BioSniper tracks 1 clinical trial involving sitravatinib.
Get deeper analysis on sitravatinib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis